Global Albumin (as Excipient) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Albumin (as Excipient) market size was valued at USD 4466.1 million in 2023 and is forecast to a readjusted size of USD 6643.7 million by 2030 with a CAGR of 5.8% during review period.

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.

By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

The Global Info Research report includes an overview of the development of the Albumin (as Excipient) industry chain, the market status of Cell Culture Media (Human Serum Albumin, Recombinant Albumin), Medical Supplements (Human Serum Albumin, Recombinant Albumin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Albumin (as Excipient).

Regionally, the report analyzes the Albumin (as Excipient) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Albumin (as Excipient) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Albumin (as Excipient) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Albumin (as Excipient) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Human Serum Albumin, Recombinant Albumin).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Albumin (as Excipient) market.

Regional Analysis: The report involves examining the Albumin (as Excipient) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Albumin (as Excipient) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Albumin (as Excipient):
Company Analysis: Report covers individual Albumin (as Excipient) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Albumin (as Excipient) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cell Culture Media, Medical Supplements).

Technology Analysis: Report covers specific technologies relevant to Albumin (as Excipient). It assesses the current state, advancements, and potential future developments in Albumin (as Excipient) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Albumin (as Excipient) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Albumin (as Excipient) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Human Serum Albumin
    Recombinant Albumin

Market segment by Application
    Cell Culture Media
    Medical Supplements
    Therapeutics

Major players covered
    CSL
    Grifols
    Takeda
    Octapharma
    Hualan Bio
    CBPO
    Shanghai RAAS
    Kedrion
    LFB Group
    Albumedix
    Biotest
    Merck
    Ventria (InVitria)
    HiMedia

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Albumin (as Excipient) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albumin (as Excipient), with price, sales, revenue and global market share of Albumin (as Excipient) from 2019 to 2024.
Chapter 3, the Albumin (as Excipient) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albumin (as Excipient) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Albumin (as Excipient) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin (as Excipient).
Chapter 14 and 15, to describe Albumin (as Excipient) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Albumin (as Excipient)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Albumin (as Excipient) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Human Serum Albumin
        1.3.3 Recombinant Albumin
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Albumin (as Excipient) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Cell Culture Media
        1.4.3 Medical Supplements
        1.4.4 Therapeutics
    1.5 Global Albumin (as Excipient) Market Size & Forecast
        1.5.1 Global Albumin (as Excipient) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Albumin (as Excipient) Sales Quantity (2019-2030)
        1.5.3 Global Albumin (as Excipient) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 CSL
        2.1.1 CSL Details
        2.1.2 CSL Major Business
        2.1.3 CSL Albumin (as Excipient) Product and Services
        2.1.4 CSL Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 CSL Recent Developments/Updates
    2.2 Grifols
        2.2.1 Grifols Details
        2.2.2 Grifols Major Business
        2.2.3 Grifols Albumin (as Excipient) Product and Services
        2.2.4 Grifols Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Grifols Recent Developments/Updates
    2.3 Takeda
        2.3.1 Takeda Details
        2.3.2 Takeda Major Business
        2.3.3 Takeda Albumin (as Excipient) Product and Services
        2.3.4 Takeda Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Takeda Recent Developments/Updates
    2.4 Octapharma
        2.4.1 Octapharma Details
        2.4.2 Octapharma Major Business
        2.4.3 Octapharma Albumin (as Excipient) Product and Services
        2.4.4 Octapharma Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Octapharma Recent Developments/Updates
    2.5 Hualan Bio
        2.5.1 Hualan Bio Details
        2.5.2 Hualan Bio Major Business
        2.5.3 Hualan Bio Albumin (as Excipient) Product and Services
        2.5.4 Hualan Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Hualan Bio Recent Developments/Updates
    2.6 CBPO
        2.6.1 CBPO Details
        2.6.2 CBPO Major Business
        2.6.3 CBPO Albumin (as Excipient) Product and Services
        2.6.4 CBPO Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 CBPO Recent Developments/Updates
    2.7 Shanghai RAAS
        2.7.1 Shanghai RAAS Details
        2.7.2 Shanghai RAAS Major Business
        2.7.3 Shanghai RAAS Albumin (as Excipient) Product and Services
        2.7.4 Shanghai RAAS Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Shanghai RAAS Recent Developments/Updates
    2.8 Kedrion
        2.8.1 Kedrion Details
        2.8.2 Kedrion Major Business
        2.8.3 Kedrion Albumin (as Excipient) Product and Services
        2.8.4 Kedrion Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Kedrion Recent Developments/Updates
    2.9 LFB Group
        2.9.1 LFB Group Details
        2.9.2 LFB Group Major Business
        2.9.3 LFB Group Albumin (as Excipient) Product and Services
        2.9.4 LFB Group Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 LFB Group Recent Developments/Updates
    2.10 Albumedix
        2.10.1 Albumedix Details
        2.10.2 Albumedix Major Business
        2.10.3 Albumedix Albumin (as Excipient) Product and Services
        2.10.4 Albumedix Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Albumedix Recent Developments/Updates
    2.11 Biotest
        2.11.1 Biotest Details
        2.11.2 Biotest Major Business
        2.11.3 Biotest Albumin (as Excipient) Product and Services
        2.11.4 Biotest Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Biotest Recent Developments/Updates
    2.12 Merck
        2.12.1 Merck Details
        2.12.2 Merck Major Business
        2.12.3 Merck Albumin (as Excipient) Product and Services
        2.12.4 Merck Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Merck Recent Developments/Updates
    2.13 Ventria (InVitria)
        2.13.1 Ventria (InVitria) Details
        2.13.2 Ventria (InVitria) Major Business
        2.13.3 Ventria (InVitria) Albumin (as Excipient) Product and Services
        2.13.4 Ventria (InVitria) Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Ventria (InVitria) Recent Developments/Updates
    2.14 HiMedia
        2.14.1 HiMedia Details
        2.14.2 HiMedia Major Business
        2.14.3 HiMedia Albumin (as Excipient) Product and Services
        2.14.4 HiMedia Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 HiMedia Recent Developments/Updates

3 Competitive Environment: Albumin (as Excipient) by Manufacturer
    3.1 Global Albumin (as Excipient) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Albumin (as Excipient) Revenue by Manufacturer (2019-2024)
    3.3 Global Albumin (as Excipient) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Albumin (as Excipient) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Albumin (as Excipient) Manufacturer Market Share in 2023
        3.4.2 Top 6 Albumin (as Excipient) Manufacturer Market Share in 2023
    3.5 Albumin (as Excipient) Market: Overall Company Footprint Analysis
        3.5.1 Albumin (as Excipient) Market: Region Footprint
        3.5.2 Albumin (as Excipient) Market: Company Product Type Footprint
        3.5.3 Albumin (as Excipient) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Albumin (as Excipient) Market Size by Region
        4.1.1 Global Albumin (as Excipient) Sales Quantity by Region (2019-2030)
        4.1.2 Global Albumin (as Excipient) Consumption Value by Region (2019-2030)
        4.1.3 Global Albumin (as Excipient) Average Price by Region (2019-2030)
    4.2 North America Albumin (as Excipient) Consumption Value (2019-2030)
    4.3 Europe Albumin (as Excipient) Consumption Value (2019-2030)
    4.4 Asia-Pacific Albumin (as Excipient) Consumption Value (2019-2030)
    4.5 South America Albumin (as Excipient) Consumption Value (2019-2030)
    4.6 Middle East and Africa Albumin (as Excipient) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Albumin (as Excipient) Sales Quantity by Type (2019-2030)
    5.2 Global Albumin (as Excipient) Consumption Value by Type (2019-2030)
    5.3 Global Albumin (as Excipient) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Albumin (as Excipient) Sales Quantity by Application (2019-2030)
    6.2 Global Albumin (as Excipient) Consumption Value by Application (2019-2030)
    6.3 Global Albumin (as Excipient) Average Price by Application (2019-2030)

7 North America
    7.1 North America Albumin (as Excipient) Sales Quantity by Type (2019-2030)
    7.2 North America Albumin (as Excipient) Sales Quantity by Application (2019-2030)
    7.3 North America Albumin (as Excipient) Market Size by Country
        7.3.1 North America Albumin (as Excipient) Sales Quantity by Country (2019-2030)
        7.3.2 North America Albumin (as Excipient) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Albumin (as Excipient) Sales Quantity by Type (2019-2030)
    8.2 Europe Albumin (as Excipient) Sales Quantity by Application (2019-2030)
    8.3 Europe Albumin (as Excipient) Market Size by Country
        8.3.1 Europe Albumin (as Excipient) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Albumin (as Excipient) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Albumin (as Excipient) Market Size by Region
        9.3.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Albumin (as Excipient) Sales Quantity by Type (2019-2030)
    10.2 South America Albumin (as Excipient) Sales Quantity by Application (2019-2030)
    10.3 South America Albumin (as Excipient) Market Size by Country
        10.3.1 South America Albumin (as Excipient) Sales Quantity by Country (2019-2030)
        10.3.2 South America Albumin (as Excipient) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Albumin (as Excipient) Market Size by Country
        11.3.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Albumin (as Excipient) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Albumin (as Excipient) Market Drivers
    12.2 Albumin (as Excipient) Market Restraints
    12.3 Albumin (as Excipient) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Albumin (as Excipient) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Albumin (as Excipient)
    13.3 Albumin (as Excipient) Production Process
    13.4 Albumin (as Excipient) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Albumin (as Excipient) Typical Distributors
    14.3 Albumin (as Excipient) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Albumin (as Excipient) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Albumin (as Excipient) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. CSL Basic Information, Manufacturing Base and Competitors
    Table 4. CSL Major Business
    Table 5. CSL Albumin (as Excipient) Product and Services
    Table 6. CSL Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. CSL Recent Developments/Updates
    Table 8. Grifols Basic Information, Manufacturing Base and Competitors
    Table 9. Grifols Major Business
    Table 10. Grifols Albumin (as Excipient) Product and Services
    Table 11. Grifols Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Grifols Recent Developments/Updates
    Table 13. Takeda Basic Information, Manufacturing Base and Competitors
    Table 14. Takeda Major Business
    Table 15. Takeda Albumin (as Excipient) Product and Services
    Table 16. Takeda Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Takeda Recent Developments/Updates
    Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
    Table 19. Octapharma Major Business
    Table 20. Octapharma Albumin (as Excipient) Product and Services
    Table 21. Octapharma Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Octapharma Recent Developments/Updates
    Table 23. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 24. Hualan Bio Major Business
    Table 25. Hualan Bio Albumin (as Excipient) Product and Services
    Table 26. Hualan Bio Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Hualan Bio Recent Developments/Updates
    Table 28. CBPO Basic Information, Manufacturing Base and Competitors
    Table 29. CBPO Major Business
    Table 30. CBPO Albumin (as Excipient) Product and Services
    Table 31. CBPO Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. CBPO Recent Developments/Updates
    Table 33. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 34. Shanghai RAAS Major Business
    Table 35. Shanghai RAAS Albumin (as Excipient) Product and Services
    Table 36. Shanghai RAAS Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Shanghai RAAS Recent Developments/Updates
    Table 38. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 39. Kedrion Major Business
    Table 40. Kedrion Albumin (as Excipient) Product and Services
    Table 41. Kedrion Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Kedrion Recent Developments/Updates
    Table 43. LFB Group Basic Information, Manufacturing Base and Competitors
    Table 44. LFB Group Major Business
    Table 45. LFB Group Albumin (as Excipient) Product and Services
    Table 46. LFB Group Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. LFB Group Recent Developments/Updates
    Table 48. Albumedix Basic Information, Manufacturing Base and Competitors
    Table 49. Albumedix Major Business
    Table 50. Albumedix Albumin (as Excipient) Product and Services
    Table 51. Albumedix Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Albumedix Recent Developments/Updates
    Table 53. Biotest Basic Information, Manufacturing Base and Competitors
    Table 54. Biotest Major Business
    Table 55. Biotest Albumin (as Excipient) Product and Services
    Table 56. Biotest Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Biotest Recent Developments/Updates
    Table 58. Merck Basic Information, Manufacturing Base and Competitors
    Table 59. Merck Major Business
    Table 60. Merck Albumin (as Excipient) Product and Services
    Table 61. Merck Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. Merck Recent Developments/Updates
    Table 63. Ventria (InVitria) Basic Information, Manufacturing Base and Competitors
    Table 64. Ventria (InVitria) Major Business
    Table 65. Ventria (InVitria) Albumin (as Excipient) Product and Services
    Table 66. Ventria (InVitria) Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. Ventria (InVitria) Recent Developments/Updates
    Table 68. HiMedia Basic Information, Manufacturing Base and Competitors
    Table 69. HiMedia Major Business
    Table 70. HiMedia Albumin (as Excipient) Product and Services
    Table 71. HiMedia Albumin (as Excipient) Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 72. HiMedia Recent Developments/Updates
    Table 73. Global Albumin (as Excipient) Sales Quantity by Manufacturer (2019-2024) & (MT)
    Table 74. Global Albumin (as Excipient) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 75. Global Albumin (as Excipient) Average Price by Manufacturer (2019-2024) & (USD/Kg)
    Table 76. Market Position of Manufacturers in Albumin (as Excipient), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 77. Head Office and Albumin (as Excipient) Production Site of Key Manufacturer
    Table 78. Albumin (as Excipient) Market: Company Product Type Footprint
    Table 79. Albumin (as Excipient) Market: Company Product Application Footprint
    Table 80. Albumin (as Excipient) New Market Entrants and Barriers to Market Entry
    Table 81. Albumin (as Excipient) Mergers, Acquisition, Agreements, and Collaborations
    Table 82. Global Albumin (as Excipient) Sales Quantity by Region (2019-2024) & (MT)
    Table 83. Global Albumin (as Excipient) Sales Quantity by Region (2025-2030) & (MT)
    Table 84. Global Albumin (as Excipient) Consumption Value by Region (2019-2024) & (USD Million)
    Table 85. Global Albumin (as Excipient) Consumption Value by Region (2025-2030) & (USD Million)
    Table 86. Global Albumin (as Excipient) Average Price by Region (2019-2024) & (USD/Kg)
    Table 87. Global Albumin (as Excipient) Average Price by Region (2025-2030) & (USD/Kg)
    Table 88. Global Albumin (as Excipient) Sales Quantity by Type (2019-2024) & (MT)
    Table 89. Global Albumin (as Excipient) Sales Quantity by Type (2025-2030) & (MT)
    Table 90. Global Albumin (as Excipient) Consumption Value by Type (2019-2024) & (USD Million)
    Table 91. Global Albumin (as Excipient) Consumption Value by Type (2025-2030) & (USD Million)
    Table 92. Global Albumin (as Excipient) Average Price by Type (2019-2024) & (USD/Kg)
    Table 93. Global Albumin (as Excipient) Average Price by Type (2025-2030) & (USD/Kg)
    Table 94. Global Albumin (as Excipient) Sales Quantity by Application (2019-2024) & (MT)
    Table 95. Global Albumin (as Excipient) Sales Quantity by Application (2025-2030) & (MT)
    Table 96. Global Albumin (as Excipient) Consumption Value by Application (2019-2024) & (USD Million)
    Table 97. Global Albumin (as Excipient) Consumption Value by Application (2025-2030) & (USD Million)
    Table 98. Global Albumin (as Excipient) Average Price by Application (2019-2024) & (USD/Kg)
    Table 99. Global Albumin (as Excipient) Average Price by Application (2025-2030) & (USD/Kg)
    Table 100. North America Albumin (as Excipient) Sales Quantity by Type (2019-2024) & (MT)
    Table 101. North America Albumin (as Excipient) Sales Quantity by Type (2025-2030) & (MT)
    Table 102. North America Albumin (as Excipient) Sales Quantity by Application (2019-2024) & (MT)
    Table 103. North America Albumin (as Excipient) Sales Quantity by Application (2025-2030) & (MT)
    Table 104. North America Albumin (as Excipient) Sales Quantity by Country (2019-2024) & (MT)
    Table 105. North America Albumin (as Excipient) Sales Quantity by Country (2025-2030) & (MT)
    Table 106. North America Albumin (as Excipient) Consumption Value by Country (2019-2024) & (USD Million)
    Table 107. North America Albumin (as Excipient) Consumption Value by Country (2025-2030) & (USD Million)
    Table 108. Europe Albumin (as Excipient) Sales Quantity by Type (2019-2024) & (MT)
    Table 109. Europe Albumin (as Excipient) Sales Quantity by Type (2025-2030) & (MT)
    Table 110. Europe Albumin (as Excipient) Sales Quantity by Application (2019-2024) & (MT)
    Table 111. Europe Albumin (as Excipient) Sales Quantity by Application (2025-2030) & (MT)
    Table 112. Europe Albumin (as Excipient) Sales Quantity by Country (2019-2024) & (MT)
    Table 113. Europe Albumin (as Excipient) Sales Quantity by Country (2025-2030) & (MT)
    Table 114. Europe Albumin (as Excipient) Consumption Value by Country (2019-2024) & (USD Million)
    Table 115. Europe Albumin (as Excipient) Consumption Value by Country (2025-2030) & (USD Million)
    Table 116. Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2019-2024) & (MT)
    Table 117. Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2025-2030) & (MT)
    Table 118. Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2019-2024) & (MT)
    Table 119. Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2025-2030) & (MT)
    Table 120. Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2019-2024) & (MT)
    Table 121. Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2025-2030) & (MT)
    Table 122. Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2019-2024) & (USD Million)
    Table 123. Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2025-2030) & (USD Million)
    Table 124. South America Albumin (as Excipient) Sales Quantity by Type (2019-2024) & (MT)
    Table 125. South America Albumin (as Excipient) Sales Quantity by Type (2025-2030) & (MT)
    Table 126. South America Albumin (as Excipient) Sales Quantity by Application (2019-2024) & (MT)
    Table 127. South America Albumin (as Excipient) Sales Quantity by Application (2025-2030) & (MT)
    Table 128. South America Albumin (as Excipient) Sales Quantity by Country (2019-2024) & (MT)
    Table 129. South America Albumin (as Excipient) Sales Quantity by Country (2025-2030) & (MT)
    Table 130. South America Albumin (as Excipient) Consumption Value by Country (2019-2024) & (USD Million)
    Table 131. South America Albumin (as Excipient) Consumption Value by Country (2025-2030) & (USD Million)
    Table 132. Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2019-2024) & (MT)
    Table 133. Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2025-2030) & (MT)
    Table 134. Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2019-2024) & (MT)
    Table 135. Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2025-2030) & (MT)
    Table 136. Middle East & Africa Albumin (as Excipient) Sales Quantity by Region (2019-2024) & (MT)
    Table 137. Middle East & Africa Albumin (as Excipient) Sales Quantity by Region (2025-2030) & (MT)
    Table 138. Middle East & Africa Albumin (as Excipient) Consumption Value by Region (2019-2024) & (USD Million)
    Table 139. Middle East & Africa Albumin (as Excipient) Consumption Value by Region (2025-2030) & (USD Million)
    Table 140. Albumin (as Excipient) Raw Material
    Table 141. Key Manufacturers of Albumin (as Excipient) Raw Materials
    Table 142. Albumin (as Excipient) Typical Distributors
    Table 143. Albumin (as Excipient) Typical Customers
List of Figures
    Figure 1. Albumin (as Excipient) Picture
    Figure 2. Global Albumin (as Excipient) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Albumin (as Excipient) Consumption Value Market Share by Type in 2023
    Figure 4. Human Serum Albumin Examples
    Figure 5. Recombinant Albumin Examples
    Figure 6. Global Albumin (as Excipient) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Albumin (as Excipient) Consumption Value Market Share by Application in 2023
    Figure 8. Cell Culture Media Examples
    Figure 9. Medical Supplements Examples
    Figure 10. Therapeutics Examples
    Figure 11. Global Albumin (as Excipient) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 12. Global Albumin (as Excipient) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 13. Global Albumin (as Excipient) Sales Quantity (2019-2030) & (MT)
    Figure 14. Global Albumin (as Excipient) Average Price (2019-2030) & (USD/Kg)
    Figure 15. Global Albumin (as Excipient) Sales Quantity Market Share by Manufacturer in 2023
    Figure 16. Global Albumin (as Excipient) Consumption Value Market Share by Manufacturer in 2023
    Figure 17. Producer Shipments of Albumin (as Excipient) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 18. Top 3 Albumin (as Excipient) Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Top 6 Albumin (as Excipient) Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Global Albumin (as Excipient) Sales Quantity Market Share by Region (2019-2030)
    Figure 21. Global Albumin (as Excipient) Consumption Value Market Share by Region (2019-2030)
    Figure 22. North America Albumin (as Excipient) Consumption Value (2019-2030) & (USD Million)
    Figure 23. Europe Albumin (as Excipient) Consumption Value (2019-2030) & (USD Million)
    Figure 24. Asia-Pacific Albumin (as Excipient) Consumption Value (2019-2030) & (USD Million)
    Figure 25. South America Albumin (as Excipient) Consumption Value (2019-2030) & (USD Million)
    Figure 26. Middle East & Africa Albumin (as Excipient) Consumption Value (2019-2030) & (USD Million)
    Figure 27. Global Albumin (as Excipient) Sales Quantity Market Share by Type (2019-2030)
    Figure 28. Global Albumin (as Excipient) Consumption Value Market Share by Type (2019-2030)
    Figure 29. Global Albumin (as Excipient) Average Price by Type (2019-2030) & (USD/Kg)
    Figure 30. Global Albumin (as Excipient) Sales Quantity Market Share by Application (2019-2030)
    Figure 31. Global Albumin (as Excipient) Consumption Value Market Share by Application (2019-2030)
    Figure 32. Global Albumin (as Excipient) Average Price by Application (2019-2030) & (USD/Kg)
    Figure 33. North America Albumin (as Excipient) Sales Quantity Market Share by Type (2019-2030)
    Figure 34. North America Albumin (as Excipient) Sales Quantity Market Share by Application (2019-2030)
    Figure 35. North America Albumin (as Excipient) Sales Quantity Market Share by Country (2019-2030)
    Figure 36. North America Albumin (as Excipient) Consumption Value Market Share by Country (2019-2030)
    Figure 37. United States Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Canada Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Mexico Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Europe Albumin (as Excipient) Sales Quantity Market Share by Type (2019-2030)
    Figure 41. Europe Albumin (as Excipient) Sales Quantity Market Share by Application (2019-2030)
    Figure 42. Europe Albumin (as Excipient) Sales Quantity Market Share by Country (2019-2030)
    Figure 43. Europe Albumin (as Excipient) Consumption Value Market Share by Country (2019-2030)
    Figure 44. Germany Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. France Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. United Kingdom Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Russia Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Italy Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Type (2019-2030)
    Figure 50. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Application (2019-2030)
    Figure 51. Asia-Pacific Albumin (as Excipient) Sales Quantity Market Share by Region (2019-2030)
    Figure 52. Asia-Pacific Albumin (as Excipient) Consumption Value Market Share by Region (2019-2030)
    Figure 53. China Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Japan Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Korea Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. India Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Southeast Asia Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Australia Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. South America Albumin (as Excipient) Sales Quantity Market Share by Type (2019-2030)
    Figure 60. South America Albumin (as Excipient) Sales Quantity Market Share by Application (2019-2030)
    Figure 61. South America Albumin (as Excipient) Sales Quantity Market Share by Country (2019-2030)
    Figure 62. South America Albumin (as Excipient) Consumption Value Market Share by Country (2019-2030)
    Figure 63. Brazil Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Argentina Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Type (2019-2030)
    Figure 66. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Application (2019-2030)
    Figure 67. Middle East & Africa Albumin (as Excipient) Sales Quantity Market Share by Region (2019-2030)
    Figure 68. Middle East & Africa Albumin (as Excipient) Consumption Value Market Share by Region (2019-2030)
    Figure 69. Turkey Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Egypt Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Saudi Arabia Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. South Africa Albumin (as Excipient) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Albumin (as Excipient) Market Drivers
    Figure 74. Albumin (as Excipient) Market Restraints
    Figure 75. Albumin (as Excipient) Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Albumin (as Excipient) in 2023
    Figure 78. Manufacturing Process Analysis of Albumin (as Excipient)
    Figure 79. Albumin (as Excipient) Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Companies Mentioned

CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia